SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-24-059821
Filing Date
2024-07-08
Accepted
2024-07-08 16:15:15
Documents
15
Period of Report
2024-07-01
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0209059-8k_silopharma.htm   iXBRL 8-K 27803
2 EXCLUSIVE LICENSE AGREEMENT WITH COLUMBIA UNIVERSITY ea020905901ex10-1_silo.htm EX-10.1 282340
3 PRESS RELEASE DATED, JULY 8, 2024 ea020905901ex99-1_silo.htm EX-99.1 8319
  Complete submission text file 0001213900-24-059821.txt   544517

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE silo-20240701.xsd EX-101.SCH 3021
5 XBRL LABEL FILE silo-20240701_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE silo-20240701_pre.xml EX-101.PRE 22363
17 EXTRACTED XBRL INSTANCE DOCUMENT ea0209059-8k_silopharma_htm.xml XML 3566
Mailing Address 677 N. WASHINGTON BLVD SARASOTA FL 34236
Business Address 677 N. WASHINGTON BLVD SARASOTA FL 34236 (718) 400-9031
Silo Pharma, Inc. (Filer) CIK: 0001514183 (see all company filings)

IRS No.: 462137136 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41512 | Film No.: 241104890
SIC: 2300 Apparel & Other Finishd Prods of Fabrics & Similar Matl
(CF Office: 04 Manufacturing)